202 related articles for article (PubMed ID: 12562773)
1. NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
Hsu ST; Breukink E; Bierbaum G; Sahl HG; de Kruijff B; Kaptein R; van Nuland NA; Bonvin AM
J Biol Chem; 2003 Apr; 278(15):13110-7. PubMed ID: 12562773
[TBL] [Abstract][Full Text] [Related]
2. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
[TBL] [Abstract][Full Text] [Related]
3. Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
Böttiger T; Schneider T; Martínez B; Sahl HG; Wiedemann I
Appl Environ Microbiol; 2009 Jul; 75(13):4427-34. PubMed ID: 19429551
[TBL] [Abstract][Full Text] [Related]
4. Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics.
Prasch T; Naumann T; Markert RL; Sattler M; Schubert W; Schaal S; Bauch M; Kogler H; Griesinger C
Eur J Biochem; 1997 Mar; 244(2):501-12. PubMed ID: 9119018
[TBL] [Abstract][Full Text] [Related]
5. Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity.
Panina IS; Balandin SV; Tsarev AV; Chugunov AO; Tagaev AA; Finkina EI; Antoshina DV; Sheremeteva EV; Paramonov AS; Rickmeyer J; Bierbaum G; Efremov RG; Shenkarev ZO; Ovchinnikova TV
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674846
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
7. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
Brötz H; Bierbaum G; Reynolds PE; Sahl HG
Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate.
Van Den Hooven HW; Doeland CC; Van De Kamp M; Konings RN; Hilbers CW; Van De Ven FJ
Eur J Biochem; 1996 Jan; 235(1-2):382-93. PubMed ID: 8631358
[TBL] [Abstract][Full Text] [Related]
9. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge.
Uteng M; Hauge HH; Markwick PR; Fimland G; Mantzilas D; Nissen-Meyer J; Muhle-Goll C
Biochemistry; 2003 Oct; 42(39):11417-26. PubMed ID: 14516192
[TBL] [Abstract][Full Text] [Related]
11. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives.
Laederach A; Andreotti AH; Fulton DB
Biochemistry; 2002 Oct; 41(41):12359-68. PubMed ID: 12369825
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles.
Vignal E; Chavanieu A; Roch P; Chiche L; Grassy G; Calas B; Aumelas A
Eur J Biochem; 1998 Apr; 253(1):221-8. PubMed ID: 9578480
[TBL] [Abstract][Full Text] [Related]
13. Expanding role of lipid II as a target for lantibiotics.
Martin NI; Breukink E
Future Microbiol; 2007 Oct; 2(5):513-25. PubMed ID: 17927474
[TBL] [Abstract][Full Text] [Related]
14. NMR evidence for a conformational adaptation of apolipophorin III upon lipid association.
Wang J; Sahoo D; Sykes BD; Ryan RO
Biochem Cell Biol; 1998; 76(2-3):276-83. PubMed ID: 9923696
[TBL] [Abstract][Full Text] [Related]
15. Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.
Wenzel M; Kohl B; Münch D; Raatschen N; Albada HB; Hamoen L; Metzler-Nolte N; Sahl HG; Bandow JE
Antimicrob Agents Chemother; 2012 Nov; 56(11):5749-57. PubMed ID: 22926563
[TBL] [Abstract][Full Text] [Related]
16. The use of dodecylphosphocholine micelles in solution NMR.
Kallick DA; Tessmer MR; Watts CR; Li CY
J Magn Reson B; 1995 Oct; 109(1):60-5. PubMed ID: 8581309
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the conformation and electrostatic surface properties of magainin peptides bound to sodium dodecyl sulfate and dodecylphosphocholine micelles.
Hicks RP; Mones E; Kim H; Koser BW; Nichols DA; Bhattacharjee AK
Biopolymers; 2003 Apr; 68(4):459-70. PubMed ID: 12666172
[TBL] [Abstract][Full Text] [Related]
18. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
19. Peptide conformational changes induced by tryptophan-phosphocholine interactions in a micelle.
Neidigh JW; Andersen NH
Biopolymers; 2002 Dec; 65(5):354-61. PubMed ID: 12389215
[TBL] [Abstract][Full Text] [Related]
20. Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.
Szekat C; Jack RW; Skutlarek D; Färber H; Bierbaum G
Appl Environ Microbiol; 2003 Jul; 69(7):3777-83. PubMed ID: 12839744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
